These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Availability of Advanced Breast Imaging at Screening Facilities Serving Vulnerable Populations. Lee CI; Bogart A; Germino JC; Goldman LE; Hubbard RA; Haas JS; Hill DA; Tosteson AN; Alford-Teaster JA; DeMartini WB; Lehman CD; Onega TL J Med Screen; 2016 Mar; 23(1):24-30. PubMed ID: 26078275 [TBL] [Abstract][Full Text] [Related]
4. Timeliness of abnormal screening and diagnostic mammography follow-up at facilities serving vulnerable women. Goldman LE; Walker R; Hubbard R; Kerlikowske K; Med Care; 2013 Apr; 51(4):307-14. PubMed ID: 23358386 [TBL] [Abstract][Full Text] [Related]
5. An assessment of the quality of mammography care at facilities treating medically vulnerable populations. Goldman LE; Haneuse SJ; Miglioretti DL; Kerlikowske K; Buist DS; Yankaskas B; Smith-Bindman R; Med Care; 2008 Jul; 46(7):701-8. PubMed ID: 18580389 [TBL] [Abstract][Full Text] [Related]
6. Variability of interpretive accuracy among diagnostic mammography facilities. Jackson SL; Taplin SH; Sickles EA; Abraham L; Barlow WE; Carney PA; Geller B; Berns EA; Cutter GR; Elmore JG J Natl Cancer Inst; 2009 Jun; 101(11):814-27. PubMed ID: 19470953 [TBL] [Abstract][Full Text] [Related]
7. Mammography facilities serving vulnerable women have longer follow-up times. Karliner LS; Kaplan C; Livaudais-Toman J; Kerlikowske K Health Serv Res; 2019 Feb; 54 Suppl 1(Suppl 1):226-233. PubMed ID: 30394526 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammography. Hubbard RA; Zhu W; Horblyuk R; Karliner L; Sprague BL; Henderson L; Lee D; Onega T; Buist DS; Sweet A Breast Cancer Res Treat; 2013 Apr; 138(3):879-87. PubMed ID: 23471650 [TBL] [Abstract][Full Text] [Related]
9. Mammography facility characteristics associated with interpretive accuracy of screening mammography. Taplin S; Abraham L; Barlow WE; Fenton JJ; Berns EA; Carney PA; Cutter GR; Sickles EA; Carl D; Elmore JG J Natl Cancer Inst; 2008 Jun; 100(12):876-87. PubMed ID: 18544742 [TBL] [Abstract][Full Text] [Related]
10. Association Between False-Positive Results and Return to Screening Mammography in the Breast Cancer Surveillance Consortium Cohort. Miglioretti DL; Abraham L; Sprague BL; Lee CI; Bissell MCS; Ho TH; Bowles EJA; Henderson LM; Hubbard RA; Tosteson ANA; Kerlikowske K Ann Intern Med; 2024 Oct; 177(10):1297-1307. PubMed ID: 39222505 [TBL] [Abstract][Full Text] [Related]
11. Radiologist characteristics associated with interpretive performance of diagnostic mammography. Miglioretti DL; Smith-Bindman R; Abraham L; Brenner RJ; Carney PA; Bowles EJ; Buist DS; Elmore JG J Natl Cancer Inst; 2007 Dec; 99(24):1854-63. PubMed ID: 18073379 [TBL] [Abstract][Full Text] [Related]
12. Multilevel Factors Associated With Time to Biopsy After Abnormal Screening Mammography Results by Race and Ethnicity. Lawson MB; Bissell MCS; Miglioretti DL; Eavey J; Chapman CH; Mandelblatt JS; Onega T; Henderson LM; Rauscher GH; Kerlikowske K; Sprague BL; Bowles EJA; Gard CC; Parsian S; Lee CI JAMA Oncol; 2022 Aug; 8(8):1115-1126. PubMed ID: 35737381 [TBL] [Abstract][Full Text] [Related]
13. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Hubbard RA; Kerlikowske K; Flowers CI; Yankaskas BC; Zhu W; Miglioretti DL Ann Intern Med; 2011 Oct; 155(8):481-92. PubMed ID: 22007042 [TBL] [Abstract][Full Text] [Related]
14. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? Braithwaite D; Zhu W; Hubbard RA; O'Meara ES; Miglioretti DL; Geller B; Dittus K; Moore D; Wernli KJ; Mandelblatt J; Kerlikowske K; J Natl Cancer Inst; 2013 Mar; 105(5):334-41. PubMed ID: 23385442 [TBL] [Abstract][Full Text] [Related]
15. Advanced Breast Imaging Availability by Screening Facility Characteristics. Lee CI; Bogart A; Hubbard RA; Obadina ET; Hill DA; Haas JS; Tosteson AN; Alford-Teaster JA; Sprague BL; DeMartini WB; Lehman CD; Onega TL Acad Radiol; 2015 Jul; 22(7):846-52. PubMed ID: 25851643 [TBL] [Abstract][Full Text] [Related]
16. Effect of false-positive mammograms on interval breast cancer screening in a health maintenance organization. Burman ML; Taplin SH; Herta DF; Elmore JG Ann Intern Med; 1999 Jul; 131(1):1-6. PubMed ID: 10391809 [TBL] [Abstract][Full Text] [Related]
17. Racial differences in false-positive mammogram rates: results from the ACRIN Digital Mammographic Imaging Screening Trial (DMIST). McCarthy AM; Yamartino P; Yang J; Bristol M; Conant EF; Armstrong K Med Care; 2015 Aug; 53(8):673-8. PubMed ID: 26125419 [TBL] [Abstract][Full Text] [Related]
18. Physician predictors of mammographic accuracy. Smith-Bindman R; Chu P; Miglioretti DL; Quale C; Rosenberg RD; Cutter G; Geller B; Bacchetti P; Sickles EA; Kerlikowske K J Natl Cancer Inst; 2005 Mar; 97(5):358-67. PubMed ID: 15741572 [TBL] [Abstract][Full Text] [Related]
19. Effects of digital mammography uptake on downstream breast-related care among older women. Hubbard RA; Zhu W; Onega TL; Fishman P; Henderson LM; Tosteson AN; Buist DS Med Care; 2012 Dec; 50(12):1053-9. PubMed ID: 23132199 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic Mammography Performance across Racial and Ethnic Groups in a National Network of Community-Based Breast Imaging Facilities. Nyante SJ; Abraham L; Aiello Bowles EJ; Lee CI; Kerlikowske K; Miglioretti DL; Sprague BL; Henderson LM; Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1324-1333. PubMed ID: 35712862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]